Long‐term safety and efficacy of exenatide twice daily in Japanese patients with suboptimally controlled type 2 diabetes

Aims/Introduction:  We assessed the long‐term (52 weeks) safety and efficacy of exenatide b.i.d. in Japanese patients with type 2 diabetes and suboptimal glycemic control. Materials and Methods:  Participants completing a 24‐week randomized controlled trial of exenatide (5 μg, 10 μg or placebo b.i.d...

Descripción completa

Detalles Bibliográficos
Autores principales: Inagaki, Nobuya, Ueki, Kohjiro, Yamamura, Ayuko, Saito, Hitoshi, Imaoka, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2011
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014904/
https://www.ncbi.nlm.nih.gov/pubmed/24843529
http://dx.doi.org/10.1111/j.2040-1124.2011.00137.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014904/
https://www.ncbi.nlm.nih.gov/pubmed/24843529
http://dx.doi.org/10.1111/j.2040-1124.2011.00137.x

Ejemplares similares